Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPORT: PF Bimatoprost vs PF Latanoprost in Glaucoma/OHT
NCT01975714Phase 4Completed
- Sponsor
- AIBILI
- Start
- Oct 2013
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 4, randomised, single-blind trial of bimatoprost in Glaucoma and ocular hypertension (2 arms), sponsored by AIBILI. Primary endpoint: Difference in mean IOP values between the 2 groups at 6 months. Started Oct 2013; status: completed.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT01975714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01975714.